Quarterly report [Sections 13 or 15(d)]

Selected Balance Sheet Data (Tables)

v3.25.4
Selected Balance Sheet Data (Tables)
6 Months Ended
Dec. 31, 2025
Notes Tables  
Schedule of inventories

Inventories consist of (in thousands):

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31, 

​

June 30, 

​

  ​ ​ ​

2025

  ​ ​ ​

2025

Raw materials

​

$

96,203

​

$

89,080

Finished goods(1)

​

 

114,842

​

 

106,188

Inventories

​

$

211,045

​

$

195,268

(1) Finished goods inventory of $5,598 and $5,822 is included within Other long-term assets in the respective December 31, 2025 and June 30, 2025. The inventory is included in long-term assets as it is forecasted to be sold after the 12 months subsequent to the Condensed Consolidated Balance Sheets dates.

Schedule of property and equipment

Property and equipment consist of (in thousands):

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31, 

​

June 30, 

​

  ​ ​ ​

2025

  ​ ​ ​

2025

Land

​

$

8,147

​

$

8,151

Buildings and improvements

​

 

257,989

​

 

254,355

Machinery and equipment

​

​

241,981

​

​

245,924

Construction in progress

​

 

19,375

​

 

23,420

Property and equipment, cost

​

 

527,492

​

 

531,850

Accumulated depreciation and amortization

​

 

(293,109)

​

 

(286,131)

Property and equipment, net

​

$

234,383

​

$

245,719

Schedule of intangible assets

Intangible assets consist of (in thousands):

​

​

​

​

​

​

​

​

​

December 31, 

​

June 30, 

​

​

2025

​

2025

Developed technology

 

$

579,907

​

$

620,062

Tradenames

 

 

94,502

​

 

152,648

Customer relationships

 

 

210,444

​

 

212,800

Patents

 

 

5,151

​

 

4,967

Other intangibles

 

 

7,149

​

 

7,174

Definite-lived intangible assets

​

 

897,153

​

 

997,651

Accumulated amortization

​

 

(562,163)

​

 

(632,052)

Total intangible assets, net

​

$

334,990

​

$

365,599

Schedule of changes in carrying amount of net intangible assets

Changes to the carrying amount of net intangible assets for the period ended December 31, 2025 consist of (in thousands):

​

​

​

​

​

  ​ ​ ​

December 31, 

​

​

2025

Beginning balance

​

$

365,599

Other additions

​

 

184

Amortization expense

​

​

(31,027)

Currency translation

​

​

234

Ending balance

​

$

334,990

Schedule of amortization expense related to intangible assets

Amortization expense related to intangible assets was as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Quarter Ended

​

Six Months Ended

​

​

December 31, 

​

December 31, 

​

​

2025

  ​ ​ ​

2024

​

2025

  ​ ​ ​

2024

Amortization expense

​

$

15,529

​

$

18,871

​

$

31,027

​

$

38,911

Schedule of estimated future amortization expense for intangible assets

The estimated future amortization expense for intangible assets as of December 31, 2025 is as follows (in thousands):

​

​

​

​

Remainder 2026

  ​ ​ ​

$

30,970

2027

​

 

58,707

2028

​

 

54,975

2029

​

 

40,881

2030

​

 

26,922

Thereafter

​

 

122,535

Total

​

$

334,990

Schedule of changes to the carrying amount of goodwill

Changes to the carrying amount of goodwill for the period ended December 31, 2025 consist of (in thousands):

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Diagnostics and

  ​ ​ ​

​

​

​

Protein Sciences

​

 Spatial Biology

​

Total

June 30, 2025

​

$

426,776

​

$

554,159

​

$

980,935

Currency translation

​

 

(885)

​

​

511

​

​

(374)

December 31, 2025

​

$

425,891

​

$

554,670

​

$

980,561

Schedule of other assets

Other assets consist of (in thousands):

​

​

​

​

​

​

​

​

  ​ ​ ​

December 31, 

​

June 30,

​

  ​ ​ ​

2025

​

2025

Equity method investment in Wilson Wolf

​

$

235,036

​

$

235,983

Long-term inventory

​

​

5,598

​

​

5,822

Investment in Spear Bio

​

​

15,000

​

​

15,000

Notes receivable(1)

​

​

7,179

​

​

2,184

Other

​

 

4,271

​

 

24,927

Other assets

​

$

267,084

​

$

283,916

(1) Amounts relate to the divestiture of our businesses held-for-sale.